Le Lézard
Classified in: Health
Subjects: PSF, CFG

Public advisory - Unauthorized prescription drug called Solmux removed from sale from Palengke Pinoy store in Camrose, AB, and Facebook store


OTTAWA, ON, Feb. 17, 2023 /CNW/ -

Summary

Solmux Carbocisteine Mucolytic, 500 mg capsule (CNW Group/Health Canada)

Affected products

Product

Prescription drug on
the label

Retailer

Solmux Carbocisteine Mucolytic,
500 mg capsule

Labelled to contain
carbocisteine

Palengke Pinoy Store

5075 50th Street

Camrose, AB

Issue
Health Canada is warning consumers about an unauthorized health product, Solmux Carbocisteine Mucolytic, that it removed from sale from Palengke Pinoy, a retail store in Camrose, AB, and an online store on Facebook. This unauthorized product was labelled to contain carbocisteine, a prescription drug for thinning mucus, which may pose serious health risks such as nausea, diarrhea, allergic reactions and gastrointestinal bleeding. It was sold as capsules in foil packets without accompanying exterior packaging and safety information.

Selling unauthorized health products in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. For example, they could contain high-risk ingredients, such as prescription drugs, additives or contaminants that may or may not be listed on the label. These ingredients could interact with other medications and foods. In addition, these products may not actually contain the active ingredients that consumers would expect them to contain to help maintain and improve their health.

Prescription drugs should only be used under the advice and supervision of a health care professional because they are used to treat specific conditions and may cause serious side effects. Prescription drugs can only be legally sold with a prescription.

 What you should do

Background

Carbocisteine is a prescription drug that is not approved for use in Canada. It is used in other countries to treat conditions associated with too much mucus in the respiratory tract. Side effects include diarrhea, nausea and heartburn. Serious allergic (e.g., anaphylactic) and skin reactions have been reported with its use. Carbocisteine can disrupt the lining of the stomach and can cause gastrointestinal bleeding in the elderly, those with a history of peptic ulcers, or patients taking medications known to cause gastrointestinal bleeds such as acetylsalicylic acid (ASA) or non-steroidal anti-inflammatory drugs (NSAIDs). The use of carbocisteine by pregnant people is not recommended.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 06:35
Merck , known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2024. "Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our...

at 06:35
Sage Therapeutics, Inc. , a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the first quarter ended March 31, 2024. "The launch of ZURZUVAE is off to...

at 06:30
Sage Veterinary Imaging (SVI) has welcomed Peter Selover to its team as president and chief operating officer. Selover had previously served as chief executive officer of Exubrion Therapeutics....

at 06:14
The Hong Kong Polytechnic University (PolyU) is partnering with ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, to expand the global impact and speed up the market penetration of PolyU's...

at 06:09
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Personalized Nutrition Market ? (By Purchase Model (Subscription, One Time Purchase), By End-users (Direct Consumers, Wellness & Fitness Centers,...

at 06:05
Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer's disease, macular degeneration, and glaucoma research grant funding?age-related diseases with no cure that affect more than 335 million people worldwide. This year's...



News published on and distributed by: